S
stranger
Guest
http://www.forbes.com/sites/aroy/2012/04/26/how-the-fda-stifles-new-cures-part-iii-a-proposal-for-reform/?utm_source=allactivity&utm_medium=rss&utm_campaign=20120426
I found the rationale for the origins of the FDA intesresting. One could argue strongly the agnecy is outdated and specifically for our audience, as the article points out, impedes progress as opposed to enabling it.
Again - I give loads of credit to the CFF & to Vertex; even with this type of obstacle in their path, they were able to find a way to bring 770 to market rapidly.
I found the rationale for the origins of the FDA intesresting. One could argue strongly the agnecy is outdated and specifically for our audience, as the article points out, impedes progress as opposed to enabling it.
Again - I give loads of credit to the CFF & to Vertex; even with this type of obstacle in their path, they were able to find a way to bring 770 to market rapidly.